These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 15626464

  • 1. Production of a monoclonal antibody to canine thymus and activation-regulated chemokine (TARC) and detection of TARC in lesional skin from dogs with atopic dermatitis.
    Maeda S, Tsukui T, Saze K, Masuda K, Ohno K, Tsujimoto H, Iwabuchi S.
    Vet Immunol Immunopathol; 2005 Jan 10; 103(1-2):83-92. PubMed ID: 15626464
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.
    J Allergy Clin Immunol; 2001 Mar 10; 107(3):535-41. PubMed ID: 11240957
    [Abstract] [Full Text] [Related]

  • 4. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis.
    Morita E, Hiragun T, Mihara S, Kaneko S, Matsuo H, Zhang Y, Dekio S.
    J Dermatol Sci; 2004 May 10; 34(3):237-40. PubMed ID: 15113595
    [Abstract] [Full Text] [Related]

  • 5. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
    Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E.
    J Allergy Clin Immunol; 2004 Feb 10; 113(2):334-40. PubMed ID: 14767451
    [Abstract] [Full Text] [Related]

  • 6. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice.
    Yoneyama H, Harada A, Imai T, Baba M, Yoshie O, Zhang Y, Higashi H, Murai M, Asakura H, Matsushima K.
    J Clin Invest; 1998 Dec 01; 102(11):1933-41. PubMed ID: 9835618
    [Abstract] [Full Text] [Related]

  • 7. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
    Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG.
    J Invest Dermatol; 2000 Oct 01; 115(4):640-6. PubMed ID: 10998136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Augmentation of CCL17 and CCL28 gene expression by TNF-alpha, IL-1beta, or IFN-gamma in cultured canine keratinocytes.
    Shibata S, Maeda S, Maeda S, Chimura N, Kondo N, Fukata T.
    Res Vet Sci; 2010 Jun 01; 88(3):422-6. PubMed ID: 20022349
    [Abstract] [Full Text] [Related]

  • 10. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A.
    Allergy; 2005 May 01; 60(5):685-8. PubMed ID: 15813816
    [Abstract] [Full Text] [Related]

  • 11. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
    Furukawa H, Nakamura K, Zheng X, Tojo M, Oyama N, Akiba H, Nishibu A, Kaneko F, Tsunemi Y, Saeki H, Tamaki K.
    J Dermatol Sci; 2004 Jun 01; 35(1):35-42. PubMed ID: 15194145
    [Abstract] [Full Text] [Related]

  • 12. Lesional expression of thymus and activation-regulated chemokine in canine atopic dermatitis.
    Maeda S, Fujiwara S, Omori K, Kawano K, Kurata K, Masuda K, Ohno K, Tsujimoto H.
    Vet Immunol Immunopathol; 2002 Sep 06; 88(1-2):79-87. PubMed ID: 12088647
    [Abstract] [Full Text] [Related]

  • 13. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases.
    Saeki H, Tamaki K.
    J Dermatol Sci; 2006 Aug 06; 43(2):75-84. PubMed ID: 16859899
    [Abstract] [Full Text] [Related]

  • 14. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis.
    Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T, Harada S, Fukunaga A, Chantry D, Gray PW, Morita A, Suzuki R, Tezuka T, Ichihashi M, Yoshie O.
    Int Immunol; 2002 Jul 06; 14(7):767-73. PubMed ID: 12096036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
    Vestergaard C, Johansen C, Christensen U, Just H, Hohwy T, Deleuran M.
    Exp Dermatol; 2004 Sep 06; 13(9):551-7. PubMed ID: 15335355
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H, Takahashi M, Nakamura K, Kaneko F.
    J Dermatol Sci; 2004 Dec 06; 36(3):165-72. PubMed ID: 15541638
    [Abstract] [Full Text] [Related]

  • 19. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK, Newton SB, Bach TL, Budgin JB, Benoit BM, Lin JH, Yoon JS, Wysocka M, Abrams CS, Rook AH.
    Am J Hematol; 2007 Sep 06; 82(9):792-7. PubMed ID: 17546636
    [Abstract] [Full Text] [Related]

  • 20. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
    Song TW, Sohn MH, Kim ES, Kim KW, Kim KE.
    Clin Exp Allergy; 2006 Mar 06; 36(3):346-51. PubMed ID: 16499646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.